Translate page

Collage Stokłosa HochhausJune 2025 - Join us for our next iCMLf Conversation on Tuesday, July 22nd 2025 at 14.00 CEST where international CML experts will review and discuss the most important biological and clinical updates presented during EHA2025.

Whether you attended EHA2025 or not, this session will summarise CML highlights into the most important takeaways for the CML community.

📅 Date: Tuesday, July 22nd
🕑 Time: 14:00 CEST
🖥️ Format: Live webinar on Zoom

Logo EHA 2025

We're bringing you daily updates from the CML sessions at EHA2025 Congress. Check back each day for updates on the day's sessions.

Stay tuned for more coverage of CML @ EHA2025 over the next few days!

Logo EHA 2025

May 2025 - The countdown to the European Hematology Association (EHA) 2025 Congress has begun! From June 12-15 in Milan, the international CML community will come together to explore groundbreaking developments in CML biology, therapy, and patient care. 

To make sure you don’t miss any important sessions and discussions, we have compiled an overview of CML related sessions at EHA2025 Congress for you.

Read on for more information...

3

In 1999, the first tyrosine kinase inhibitor (TKI) transformed the treatment of chronic myeloid leukemia - and changed the course of cancer care worldwide.

This year, we mark 25 years since that breakthrough. It’s more than a scientific milestone - it’s a story of lives extended and a global community working to ensure access to treatment for all.

To honor this anniversary, the iCMLf is sharing reflections, resources, and real-world impact from across our network:

3

Since 2020, Isabella has been raising money for the iCMLf in honor of her mum, who was diagnosed with CML that year. Over the years, she’s run fun runs, rallied her school community, and inspired people around the world with her determination and heart.

And she’s not done yet.

 

 

Brian TKIsAs part of the iCMLf’s 25 Years of TKIs campaign, we spoke to Dr. Brian Druker - whose work helped transform CML from a fatal disease to a manageable condition. He shared the moments that shaped this journey, the challenges along the way, and the hope that still drives him today.